995 related articles for article (PubMed ID: 21385205)
1. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
2. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
3. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
4. Hemangiomas of the nasal tip treated with propranolol.
Ben-Amitai D; Halachmi S; Zvulunov A; Raveh E; Kalish E; Lapidoth M
Dermatology; 2012; 225(4):371-5. PubMed ID: 23428617
[TBL] [Abstract][Full Text] [Related]
5. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
6. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
7. β-blockers for infantile hemangiomas: a single-institution experience.
Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
[TBL] [Abstract][Full Text] [Related]
8. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
9. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
[TBL] [Abstract][Full Text] [Related]
10. [Propanolol used in treatment of infantile hemangioma].
Guldbakke KK; Rørdam OM; Huldt-Nystrøm T; Hanssen HK; Høivik F
Tidsskr Nor Laegeforen; 2010 Sep; 130(18):1822-4. PubMed ID: 20882080
[TBL] [Abstract][Full Text] [Related]
11. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
12. Use of propranolol for infantile hemangiomas.
Küpeli S
Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
[TBL] [Abstract][Full Text] [Related]
13. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
[TBL] [Abstract][Full Text] [Related]
14. [Propranolol for the treatment of severe hemangiomas of infancy: results from a series of 28 patients].
Bernabeu-Wittel J; Pereyra-Rodríguez JJ; Mantrana-Bermejo ME; Fernández-Pineda I; de Agustín JC; Conejo-Mir J
Actas Dermosifiliogr; 2011 Sep; 102(7):510-6. PubMed ID: 21514550
[TBL] [Abstract][Full Text] [Related]
15. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
[TBL] [Abstract][Full Text] [Related]
17. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of propranolol treatment for patients with infantile hemangioma.
Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
[TBL] [Abstract][Full Text] [Related]
19. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
20. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]